ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Indo Us Bio-Tech reconstituted its Audit, Nomination, and Stakeholders committees effective July 10, 2026. This follows the earlier appointment of Hemanshi Darsh Soni as Additional Director.
Indo Us Bio-Tech Limited filed its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report details governance compliance and historical regulatory observations.
Indo Us Bio-Tech Ltd submitted its compliance certificate under Regulation 74(5) for the quarter and year ended March 31, 2026. The registrar, Bigshare Services, confirmed that no securities were received for dematerialization during this period. This is a routine regulatory filing with no material impact on business operations.